CD4 and inflammatory bowel disease: Excessive activation of effector CD4+ T cells and/or reductions in CD4+ T cell-mediated tolerance to gut antigens are thought to play a role in the development of the two most common forms of IBD, ulcerative colitis (UC) and Crohn’s disease (CD) [1, 2].